Comprehensive Genomic Profiling Panel
An NGS-Based Test for Myeloid Leukemia
When cancer is diagnosed, finding treatment options is the top priority
OncoTarget® Series is our comprehensive genomic profiling solution to identify targeted immunotherapies
for advanced cancers – solid tumors or leukemias.
GoPath® Diagnostics Launches FDA-Cleared CGP Test under OncoTarget® 500
OncoTarget®500 genomic profiling identifies tumor-based somatic mutations with high accuracy and sensitivity – single nucleotide variants (SNVs), small insertions and deletions, amplifications, translocations, microsatellite instability (MSI) and tumor mutation burden (TMB). OncoTarget®500 is designed to be used by qualified healthcare professionals according to professional guidelines in oncology for previously diagnosed cancer patients.
Begin your journey. Our team is ready to get you started.